
    
      Patients will be treated with vemurafenib plus radiation therapy (RT) based upon the
      administration schedule. The starting dose of vemurafenib will be the patient's baseline
      tolerating dose, between 720 - and 960 mg by mouth. Patients must be tolerating at a minimum
      720mg for one cycle (28 days) prior to enrollment.
    
  